Investigation of the Mechanisms and Experimental Verification of Yulin Formula in the Treatment of Diminished Ovarian Reserve via Network Pharmacology

References

• Scantamburlo VM, Linsingen RV, Centa LJR, et al. Association between decreased ovarian reserve and poor oocyte quality. Obstet Gynecol Sci. 2021;64(6):532–539. doi:10.5468/ogs.20168
   PubMedGoogle Scholar
• Hu S, Xu B, Jin L. Perinatal outcome in young patients with diminished ovarian reserve undergoing assisted reproductive technology. Fertil Steril. 2020;114(1):118–24.e1. doi:10.1016/j.fertnstert.2020.02.112
   PubMed Web of Science ®Google Scholar
• Tal R, Seifer DB. Ovarian reserve testing: a user’s guide. Am J Obstet Gynecol. 2017;217(2):129–140. doi:10.1016/j.ajog.2017.02.027
   PubMed Web of Science ®Google Scholar
• Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12(6):685–718. doi:10.1093/humupd/dml034
   PubMed Web of Science ®Google Scholar
• Zhang QL, Lei YL, Deng Y, et al. Treatment progress in diminished ovarian reserve: Western and Chinese medicine. Chin J Integr Med. 2022;29(4):361–367. doi:10.1007/s11655-021-3353-2
   PubMed Web of Science ®Google Scholar
• D’Alonzo M, Bounous VE, Villa M, Biglia N. Current evidence of the oncological benefit-risk profile of hormone replacement therapy. Medicina. 2019;55(9):573. doi:10.3390/medicina55090573
   PubMedGoogle Scholar
• Neves AR, Montoya-Botero P, Polyzos NP. Androgens and diminished ovarian reserve: the long road from basic science to clinical implementation. A comprehensive and systematic review with meta-analysis. Am J Obstet Gynecol. 2022;227(3):401–13.e18. doi:10.1016/j.ajog.2022.03.051
   PubMed Web of Science ®Google Scholar
• Xia T, Ma R-H, Mu W, et al. Traditional Chinese medicine for diminished ovarian reserve: a systematic review and meta-analysis. Chin Herb Med. 2014;6(02):93–102.
   Google Scholar
• Liu W, Chen Q, Liu Z, et al. Zihuai recipe alleviates cyclophosphamide-induced diminished ovarian reserve via suppressing PI3K/AKT-mediated apoptosis. J Ethnopharmacol. 2021;277:113789. doi:10.1016/j.jep.2021.113789
   PubMed Web of Science ®Google Scholar
• Zou LSC, Chen B, Gao W, Weijiang C. Research on the construction status and suggestions of the first batch of “national academic school of traditional Chinese medicine inheritance studio construction units” in Zhejiang Province. J Zhejiang Univ Tradit Chin Med. 2020;2020:44.
   Google Scholar
• Jialin H, Jia Y. Efficacy of Yulin Formula with addition and reduction in the treatment of 30 cases of decreased ovarian reserve function in women of different ages. Chin J Tradit Med Sci Technol. 2011;18(06).
   Google Scholar
• Bin-bin C, Jialin H, Su-xia W. Effects of Yulin decoction on secretion function of granulosa cells of ovarian reserve declined rats. Chin J Exp Tradit Med Formulae. 2015;21(15):1.
   Google Scholar
• Binbin C, Su-xia W, Yu-tian Z, Jialin H, Xiaohong F. Effects of Yulin Formula on ultra structure of ovarian granulosa cells in diminished ovarian reserve rats. China J Traditi Chin Med Pharm. 2020;35(6):1.
   Google Scholar
• Ru J, Li P, Wang J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:13. doi:10.1186/1758-2946-6-13
   PubMed Web of Science ®Google Scholar
• Yang L, Zhao Y, Xu H, et al. Network pharmacology-based prediction and verification of the potential mechanisms of He’s Yangchao Formula against diminished ovarian reserve. Evid Based Complement Alternat Med. 2022;2022:8361808. doi:10.1155/2022/8361808
   PubMed Web of Science ®Google Scholar
• Bateman A, Martin M-J, Orchard S. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 2021;49(D1):D480–D489. doi:10.1093/nar/gkaa1100
   PubMed Web of Science ®Google Scholar
• Stelzer G, Dalah I, Stein TI, et al. In-silico human genomics with GeneCards. Hum Genomics. 2011;5(6):709–717. doi:10.1186/1479-7364-5-6-709
   PubMedGoogle Scholar
• Amberger JS, Bocchini CA, Schiettecatte F, Scott AF, Hamosh A. OMIM.org: online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders. Nucleic Acids Res. 2015;43(Database issue):D789–D798. doi:10.1093/nar/gku1205
   PubMed Web of Science ®Google Scholar
• Zhang H, Yao S, Zhang Z, et al. Network pharmacology and experimental validation to reveal the pharmacological mechanisms of liuwei dihuang decoction against intervertebral disc degeneration. Drug Des Devel Ther. 2021;15:4911–4924. doi:10.2147/DDDT.S338439
   PubMed Web of Science ®Google Scholar
• Zhang YY, Ma JX, Zhu YT, et al. Investigation of the mechanisms and experimental verification of Cuscuta-Salvia in the treatment of polycystic ovary syndrome (PCOS) via network pharmacology. J Ovarian Res. 2022;15(1):40. doi:10.1186/s13048-022-00964-8
   PubMed Web of Science ®Google Scholar
• Luo W, Brouwer C. Pathview: an R/Bioconductor package for pathway-based data integration and visualization. Bioinformatics. 2013;29(14):1830–1831. doi:10.1093/bioinformatics/btt285
   PubMed Web of Science ®Google Scholar
• Jiang M, Wang W, Zhang J, et al. Protective effects and possible mechanisms of actions of bushen cuyun recipe on diminished ovarian reserve induced by cyclophosphamide in rats. Front Pharmacol. 2020;11:546. doi:10.3389/fphar.2020.00546
   PubMed Web of Science ®Google Scholar
• Kesharwani DK, Mohammad S, Acharya N, Joshi KS. Fertility with early reduction of ovarian reserve. Cureus. 2022;14(10):e30326. doi:10.7759/cureus.30326
   PubMed Web of Science ®Google Scholar
• Glamoclija V, Vilovic K, Saraga-Babic M, Baranovic A, Sapunar D. Apoptosis and active caspase-3 expression in human granulosa cells. Fertil Steril. 2005;83(2):426–431. doi:10.1016/j.fertnstert.2004.06.075
   PubMed Web of Science ®Google Scholar
• Bulgurcuoglu Kuran S, Altun A, Karamustafaoglu Balci B, Keskin I, Hocaoglu M. Expression of pro-apoptotic and anti-apoptotic proteins in granulosa cells of women with diminished ovarian reserve. J Assist Reprod Genet. 2022;39(3):765–775. doi:10.1007/s10815-022-02422-2
   PubMed Web of Science ®Google Scholar
• Regan SLP, Knight PG, Yovich JL, et al. The effect of ovarian reserve and receptor signalling on granulosa cell apoptosis during human follicle development. Mol Cell Endocrinol. 2018;470:219–227. doi:10.1016/j.mce.2017.11.002
   PubMed Web of Science ®Google Scholar
• Nirmala JG, Lopus M. Cell death mechanisms in eukaryotes. Cell Biol Toxicol. 2020;36(2):145–164. doi:10.1007/s10565-019-09496-2
   PubMed Web of Science ®Google Scholar
• Santagostino SF, Assenmacher CA, Tarrant JC, Adedeji AO, Radaelli E. Mechanisms of regulated cell death: current perspectives. Vet Pathol. 2021;58(4):596–623. doi:10.1177/03009858211005537
   PubMed Web of Science ®Google Scholar
• Maidarti M, Anderson RA, Telfer EE. Crosstalk between PTEN/PI3K/Akt Signalling and DNA damage in the oocyte: implications for primordial follicle activation, oocyte quality and ageing. Cells. 2020;9(1):200. doi:10.3390/cells9010200
   PubMed Web of Science ®Google Scholar
• Zhao Y, Chen Y, Miao C, et al. He’s yangchao recipe ameliorates ovarian oxidative stress of aging mice under consecutive superovulation involving JNK- and P53-related mechanism. Evid Based Complement Alternat Med. 2022;2022:7705194. doi:10.1155/2022/7705194
   PubMed Web of Science ®Google Scholar
• Liu H, Yang H, Qin Z, et al. Exploration of the danggui buxue decoction mechanism regulating the balance of ESR and AR in the TP53-AKT signaling pathway in the prevention and treatment of POF. Evid Based Complement Alternat Med. 2021;2021:4862164. doi:10.1155/2021/4862164
   PubMed Web of Science ®Google Scholar
• Luan Y, Edmonds ME, Woodruff TK, Kim SY. Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide. J Endocrinol. 2019;240(2):243–256. doi:10.1530/JOE-18-0370
   PubMed Web of Science ®Google Scholar
• Roness H, Gavish Z, Cohen Y, Meirow D. Ovarian follicle burnout: a universal phenomenon? Cell Cycle. 2013;12(20):3245–3246. doi:10.4161/cc.26358
   PubMed Web of Science ®Google Scholar